Plus Therapeutics Inc

Research Plus Therapeutics Inc (PSTV) on Bullrun: market cap USD 29.44M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerPSTV
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 29.44M
• Financial periodFY2025
• RevenueUSD 5.21M
• Revenue growth-10.5%
• Net income-USD 22.39M
• Free cash flow-USD 20.84M

Valuation Snapshot

latest market cap is USD 29.44M.

About Plus Therapeutics Inc

Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. The company's lead radiotherapeutic candidate is rhenium obisbemeda, a patented radiotherapy for patients with central nervous system and other cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers.

Frequently asked questions

What is Plus Therapeutics Inc's market cap?

Plus Therapeutics Inc's market capitalization is USD 29.44M.

What does Plus Therapeutics Inc do?

Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer.